FDA Inspection
AstraZeneca Pharmaceuticals LPFDA Inspection 601426 - AstraZeneca Pharmaceuticals LP - June 16, 2009
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on June 16, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · bc5d904d-a3aa-4c0c-8f66-ceb8716194cb
Violation Codes5
21 CFR 211.100(b)21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 600.14(a)(1)21 CFR 600.14(c)
Full citation text and observation details available on the Dashboard.